The burden of hand, foot, and mouth disease among children under different vaccination scenarios in China: a dynamic modelling study

BackgroundHand, foot, and mouth disease (HFMD) is a common illness in young children. A monovalent vaccine has been developed in China protecting against enterovirus-71, bivalent vaccines preventing HFMD caused by two viruses are under development.ObjectiveTo predict and compare the incidence of HFMD under different vaccination scenarios in China.MethodsWe developed a compartmental model to capture enterovirus transmission and the natural history of HFMD in children aged 0-5, and calibrated to reported cases in the same age-group from 2015 to 2018. We compared the following vaccination scenarios: different combinations of monovalent and bivalent vaccine; a program of constant vaccination to that of pulse vaccination prior to seasonal outbreaks.ResultsWe estimate 1,982,819, 2,258,846, 1,948,522 and 2,398,566 cases from 2015 to 2018. Increased coverage of monovalent vaccine from 0 to 80% is predicted to decrease the cases by 797,262 (49.1%). Use of bivalent vaccine at an 80% coverage level would decrease the cases by 828,560. Use of a 2.0x pulse vaccination for the bivalent vaccine in addition to 80% coverage would reduce cases by over one million. The estimated R-0 for HFMD in 2015-2018 was 1.08, 1.10, 1.35 and 1.17.ConclusionsOur results point to the benefit of bivalent vaccine and using a pulse vaccination in specific months over routine vaccination. Other ways to control HFMD include isolation of patients in the early stage of dissemination, more frequent hand-washing and ventilation, and better treatment options for patients.